| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |